» Articles » PMID: 8645102

Evaluation of the Thymidine Kinase (tk) Locus As an Insertion Site in the Highly Attenuated Vaccinia MVA Strain

Overview
Journal Arch Virol
Specialty Microbiology
Date 1996 Jan 1
PMID 8645102
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The highly attenuated 'modified vaccinia Ankara' (MVA) strain is a potential live vaccine vector. Insertional inactivation of the tk-gene resulted in viruses difficult to purify. Co-integration of a functional fowlpox virus tk-gene allowed easy generation of recombinants, indicating that the genetically stable tk-gene region is a suitable insertion site, if tk-gene activity is substituted.

Citing Articles

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.

Neckermann P, Mohr M, Billmeier M, Karlas A, Boilesen D, Thirion C Front Immunol. 2024; 15:1338492.

PMID: 38380318 PMC: 10877035. DOI: 10.3389/fimmu.2024.1338492.


A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.

Boulton S, Poutou J, Gill R, Alluqmani N, He X, Singaravelu R Mol Ther Methods Clin Dev. 2023; 31:101110.

PMID: 37822719 PMC: 10562195. DOI: 10.1016/j.omtm.2023.101110.


Generation of Recombinant Vaccinia Viruses.

Wyatt L, Earl P, Moss B Curr Protoc Protein Sci. 2017; 89:5.13.1-5.13.18.

PMID: 28762491 PMC: 5765993. DOI: 10.1002/cpps.33.


Generation of Recombinant Vaccinia Viruses.

Wyatt L, Earl P, Moss B Curr Protoc Microbiol. 2015; 39:14A.4.1-14A.4.18.

PMID: 26528782 PMC: 5123791. DOI: 10.1002/9780471729259.mc14a04s39.


SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC.

Pan Q, Huang Y, Chen L, Gu J, Zhou X Hum Cell. 2014; 27(4):162-71.

PMID: 24771354 DOI: 10.1007/s13577-014-0093-z.


References
1.
STICKL H, Hochstein-Mintzel V, Mayr A, Huber H, Schafer H, Holzner A . [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)]. Dtsch Med Wochenschr. 1974; 99(47):2386-92. DOI: 10.1055/s-0028-1108143. View

2.
Mackett M, Smith G, Moss B . Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A. 1982; 79(23):7415-9. PMC: 347350. DOI: 10.1073/pnas.79.23.7415. View

3.
Altenburger W, Suter C, Altenburger J . Partial deletion of the human host range gene in the attenuated vaccinia virus MVA. Arch Virol. 1989; 105(1-2):15-27. DOI: 10.1007/BF01311113. View

4.
Buller R, Smith G, Cremer K, Notkins A, Moss B . Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature. 1985; 317(6040):813-5. DOI: 10.1038/317813a0. View

5.
Sutter G, Wyatt L, Foley P, Bennink J, Moss B . A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine. 1994; 12(11):1032-40. DOI: 10.1016/0264-410x(94)90341-7. View